{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-005972","form_type":"8-K","ticker":"SFES","cik":"0000086115","company_name":"SAFEGUARD SCIENTIFICS INC","filed_at":"2023-03-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.297246+00:00","generated_at":"2026-06-18T08:03:20.014113+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Safeguard Scientifics posts FY2022 net loss of $14.3M vs net income of $27.0M in 2021","bullets":["Net loss Q4 2022 $4.9M ($0.30/share) vs loss $8.6M ($0.51) in Q4 2021; FY2022 net loss $14.3M ($0.87) vs net income $27.0M ($1.36) in FY2021.","Cash & securities $19.3M at Dec 31, 2022; carrying value of ownership interests $15.4M.","Annual deployments $5.7M within prior guidance of $5M-$9M; funded loans to meQuilibrium and Trice Medical.","Repurchased 711,481 shares for $2.9M in 2022 at avg $4.13; added 736,577 shares through Jan 2023 under $3M plan.","Operating costs down 33% YoY: G&A $4.8M in 2022 vs $7.2M in 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-005972","json":"https://secwatch.observer/filing/0001437749-23-005972.json","markdown":"https://secwatch.observer/filing/0001437749-23-005972.md","text":"https://secwatch.observer/filing/0001437749-23-005972.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/86115/000143774923005972/0001437749-23-005972-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/86115/000143774923005972/sfe20230308_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T08:03:20.014113+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9ac4b206da411358055624feac89c4e34e1932f1","claim":"SAFEGUARD SCIENTIFICS INC reported three months and year ended December 31, 2022 results: net income Net loss for the year ended December 31, 2022 was $14.3 million, or $0.87 per share, EPS $0.87 per share.","evidence_excerpt":"Net loss for the three months ended December 31, 2022 was $4.9 million, or $0.30 per share, compared with a net loss of $8.6 million, or $0.51 per share, for the same period in 2021.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/86115/000143774923005972/0001437749-23-005972-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months and year ended December 31, 2022"},{"label":"Net income","value":"Net loss for the year ended December 31, 2022 was $14.3 million, or $0.87 per share"},{"label":"EPS","value":"$0.87 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"9ac4b206da411358055624feac89c4e34e1932f1","claim":"SAFEGUARD SCIENTIFICS INC reported three months and year ended December 31, 2022 results: net income Net loss for the year ended December 31, 2022 was $14.3 million, or $0.87 per share, EPS $0.87 per share.","evidence_excerpt":"Net loss for the year ended December 31, 2022 was $14.3 million, or $0.87 per share, compared with net income of $27.0 million, or $1.36 per share, for the same period of 2021.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/86115/000143774923005972/0001437749-23-005972-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months and year ended December 31, 2022"},{"label":"Net income","value":"Net loss for the year ended December 31, 2022 was $14.3 million, or $0.87 per share"},{"label":"EPS","value":"$0.87 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}